今天是:2023-03-25 星期六

大气细颗粒物成分及其诱导呼吸道氧化应激与炎症的机理研究
下载XML文档

注册号:

Registration number:

ChiCTR1900023692 

最近更新日期:

Date of Last Refreshed on:

2019-06-07 

注册时间:

Date of Registration:

2019-06-07 

注册号状态:

补注册  

Registration Status:

Retrospective registration  

注册题目:

大气细颗粒物成分及其诱导呼吸道氧化应激与炎症的机理研究 

Public title:

Study for components of fine particulate matter and its mechanism of inducing oxidative stress and inflammation in respiratory tract 

注册题目简写:

 

English Acronym:

 

研究课题的正式科学名称:

大气细颗粒物成分及其诱导呼吸道氧化应激与炎症的机理研究 

Scientific title:

Study for components of fine particulate matter and its mechanism of inducing oxidative stress and inflammation in respiratory tract 

研究课题代号(代码):

Study subject ID:

 

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

 

申请注册联系人:

王腾 

研究负责人:

朱彤 

Applicant:

TENG WANG 

Study leader:

TONG ZHU 

申请注册联系人电话:

Applicant telephone:

+86 18811123279 

研究负责人电话:

Study leader's telephone:

+86 10 62754789 

申请注册联系人传真 :

Applicant Fax:

 

研究负责人传真:

Study leader's fax:

 

申请注册联系人电子邮件:

Applicant E-mail:

t.w@pku.edu.cn 

研究负责人电子邮件:

Study leader's E-mail:

tzhu@pku.edu.cn 

申请单位网址(自愿提供):

Applicant website(voluntary supply):

 

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

 

申请注册联系人通讯地址:

北京市海淀区颐和园路5号北京大学环境大楼501 

研究负责人通讯地址:

北京市海淀区颐和园路5号北京大学环境大楼501 

Applicant address:

5 Yi-He-Yuan Road, Haidian District, Beijing, China 

Study leader's address:

5 Yi-He-Yuan Road, Haidian District, Beijing, China 

申请注册联系人邮政编码:

Applicant postcode:

 

研究负责人邮政编码:

Study leader's postcode:

 

申请人所在单位:

北京大学环境科学与工程学院 

Applicant's institution:

College of Environmental Sciences and Engineering, Peking University 

是否获伦理委员会批准:

是 

Approved by ethic committee:

Yes 

伦理委员会批件文号:

Approved No. of ethic committee:

IRB00001052-15088 

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京大学生物医学伦理委员会 

Name of the ethic committee:

PU IRB 

伦理委员会批准日期:

Date of approved by ethic committee:

2018-08-14 

伦理委员会联系人:

丛亚丽 

Contact Name of the ethic committee:

Cong Yali 

伦理委员会联系地址:

北京市海淀区学院路38号北京大学医学部逸夫教学楼501室 

Contact Address of the ethic committee:

Room 501, Yifu Teaching Building, Peking University Health Science Center, 38 Xueyuan Road , Haidian District, Beijing, China 

伦理委员会联系人电话:

Contact phone of the ethic committee:

 

伦理委员会联系人邮箱:

Contact email of the ethic committee:

 

研究实施负责(组长)单位:

北京大学环境科学与工程学院 

Primary sponsor:

College of Environmental Sciences and Engineering, Peking University 

研究实施负责(组长)单位地址:

北京市海淀区颐和园路5号北京大学环境大楼501 室 

Primary sponsor's address:

Room 501, Environmental Building, Peking University, 5 Yi-He-Yuan Road, Haidian District, Beijing, China 

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学环境科学与工程学院

具体地址:

北京市海淀区颐和园路5号北京大学环境大楼501 室

Institution
hospital:

College of Environmental Sciences and Engineering, Peking University

Address:

5 Yi-He-Yuan Road, Haidian District, Beijing, China

经费或物资来源:

中国科技部 

Source(s) of funding:

Ministry of Science and Technology, China 

研究疾病:

慢性肺阻 

Target disease:

COPD 

研究疾病代码:

 

Target disease code:

 

研究类型:

观察性研究 

Study type:

Observational study 

研究所处阶段:

其它 

Study phase:

N/A 

研究目的:

1.评价实际空气环境中的PM2.5对老年人肺功能及炎症指标的影响; 2.PM2.5对呼吸系统的损伤效应在COPD人群及健康人群中的差别; 3.研究PM2.5造成呼吸系统损伤,加重呼吸系统疾病的病理机制。 

Objectives of Study:

1. To evaluate the effect of PM2.5 in the actual air environment on pulmonary function and inflammatory indicators in the elderly; 2. Differences of respiratory system injury effect of PM2.5 in COPD population and healthy population; 3. Study the pathological mechanism of respiratory system injury caused by PM2.5 and aggravating respiratory diseases. 

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

研究设计:

连续入组 

Study design:

Sequential 

纳入标准:

COPD人群入选条件主要包括:符合COPD诊断标准的患者;45-70岁之间;居住在什刹海附近地区;无3年内吸烟史。 健康人群主要入选条件包括:基本信息匹配,即与入选COPD患者年龄、性别匹配的志愿者。胸片正常。其他慢性疾病需处于良好控制状态。 

Inclusion criteria

The inclusion conditions of COPD group mainly include: patients meeting the diagnostic criteria of COPD; Between 45 and 70 years old; Live nearby Shichahai community, Xicheng district; No smoking history in 3 years. The main inclusion criteria of healthy population included: basic information matching, i.e., volunteers matched with age and gender of selected COPD patients. No history of current smoking, past smokers quit for more than 3 years, and chest radiographs were normal. Other chronic diseases need to be well controlled. 

排除标准:

正在吸烟人群或戒烟小于 3 年 

Exclusion criteria:

Smoke or quit smoking less than 3 years  

研究实施时间:

Study execute time:

From2015-01-01To 2021-08-31 

征募观察对象时间:

Recruiting time:

From2016-05-01To 2017-09-01 

干预措施:

Interventions:

组别:

Case series

样本量:

120

Group:

Case series

Sample size:

干预措施:

Nil

干预措施代码:

Intervention:

Nil

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国 

省(直辖市):

北京 

市(区县):

 

Country:

China 

Province:

Beijing 

City:

 

单位(医院):

北京大学附属第一医院 

单位级别:

三甲医院 

Institution
hospital:

Peking University First Hospital  

Level of the institution:

Tertiary A Hospital 

国家:

中国 

省(直辖市):

北京 

市(区县):

 

Country:

China 

Province:

Beijing 

City:

 

单位(医院):

北京市什刹海社区医院 

单位级别:

社区医院 

Institution
hospital:

Beijing Xicheng District Shichahai Community Health Center  

Level of the institution:

Community Health Center 

测量指标:

Outcomes:

指标中文名:

血常规

指标类型:

主要指标 

Outcome:

blood routine examination

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血糖

指标类型:

主要指标 

Outcome:

blood sugar

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血脂

指标类型:

主要指标 

Outcome:

blood lipids

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

细胞因子

指标类型:

主要指标 

Outcome:

Cytokines

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

丙二醛

指标类型:

主要指标 

Outcome:

MDA

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肺功能

指标类型:

主要指标 

Outcome:

Lung function

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁 

说明

Fate of sample:

Destruction after use 

Note:

标本中文名:

尿液

组织:

Sample Name:

Urine

Tissue:

人体标本去向

使用后销毁 

说明

Fate of sample:

Destruction after use 

Note:

标本中文名:

呼出气

组织:

Sample Name:

Exhaled gas

Tissue:

人体标本去向

使用后销毁 

说明

Fate of sample:

Destruction after use 

Note:

标本中文名:

呼出气冷凝液

组织:

Sample Name:

Exhaled breath condensate

Tissue:

人体标本去向

使用后销毁 

说明

Fate of sample:

Destruction after use 

Note:

征募研究对象情况:

Recruiting status:

结束

Completed

年龄范围:

Participant age:

最小 Min age 45 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

通过巢式病例对照设计纳入人群

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

盲法:

N/A

Blinding:

N/A

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过发表论文在相关期刊公开; ResMan

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

share data by publishing papers; ResMan

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2019-06-07
返回列表